Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France

Vaccine ◽  
2015 ◽  
Vol 33 (20) ◽  
pp. 2367-2378 ◽  
Author(s):  
Florence Ribadeau Dumas ◽  
Dieynaba S. N’Diaye ◽  
Juliette Paireau ◽  
Philippe Gautret ◽  
Hervé Bourhy ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Decision Tree ◽  
Decision Tree Model ◽  
Post Exposure Prophylaxis ◽  
Tree Model ◽  
Post Exposure ◽  
Model Based ◽  
Exposure Prophylaxis

scholarly journals Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia

HIV Medicine ◽  
2009 ◽  
Vol 10 (4) ◽  
pp. 199-208 ◽  
Author(s):  
D Guinot ◽  
MT Ho ◽  
IM Poynten ◽  
J McAllister ◽  
A Pierce ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Post Exposure Prophylaxis ◽  
Post Exposure ◽  
Exposure Prophylaxis

scholarly journals Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness

2018 ◽  
Vol 41 (2) ◽  
pp. 379-390
Author(s):  
Sudhir Venkatesan ◽  
Cristina Carias ◽  
Matthew Biggerstaff ◽  
Angela P Campbell ◽  
Jonathan S Nguyen-Van-Tam ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Cost Saving ◽  
Decision Tree ◽  
Antiviral Treatment ◽  
Decision Tree Model ◽  
High Risk Population ◽  
Tree Model ◽  
Community Based ◽  
Population Groups

Abstract Background Many countries have acquired antiviral stockpiles for pandemic influenza mitigation and a significant part of the stockpile may be focussed towards community-based treatment. Methods We developed a spreadsheet-based, decision tree model to assess outcomes averted and cost-effectiveness of antiviral treatment for outpatient use from the perspective of the healthcare payer in the UK. We defined five pandemic scenarios—one based on the 2009 A(H1N1) pandemic and four hypothetical scenarios varying in measures of transmissibility and severity. Results Community-based antiviral treatment was estimated to avert 14–23% of hospitalizations in an overall population of 62.28 million. Higher proportions of averted outcomes were seen in patients with high-risk conditions, when compared to non-high-risk patients. We found that antiviral treatment was cost-saving across pandemic scenarios for high-risk population groups, and cost-saving for the overall population in higher severity influenza pandemics. Antiviral effectiveness had the greatest influence on both the number of hospitalizations averted and on cost-effectiveness. Conclusions This analysis shows that across pandemic scenarios, antiviral treatment can be cost-saving for population groups at high risk of influenza-related complications.

scholarly journals Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model

BMC Urology ◽  
2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Salvador Arlandis-Guzman ◽  
Carlos Errando-Smet ◽  
Jeffrey Trocio ◽  
Daniel Arumi ◽  
Javier Rejas
Keyword(s):  
Cost Effectiveness ◽  
Overactive Bladder ◽  
Decision Tree ◽  
Cost Effectiveness Analysis ◽  
Decision Tree Model ◽  
Tree Model ◽  
Effectiveness Analysis

Cost effectiveness of rabies post exposure prophylaxis in the United States

Vaccine ◽  
2008 ◽  
Vol 26 (33) ◽  
pp. 4251-4255 ◽  
Author(s):  
Praveen Dhankhar ◽  
Sagar A. Vaidya ◽  
Daniel B. Fishbien ◽  
Martin I. Meltzer
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
The United States ◽  
Post Exposure Prophylaxis ◽  
Post Exposure ◽  
Exposure Prophylaxis
Sign in / Sign up

Export Citation Format

Share Document